Ovcon Articles
Warner Chilcott and Barr settle Femcon dispute
12 January 2009
US FTC settles with Barr Labs over Ovcon
10 December 2007
Watson files for generic Femcon
8 October 2007
Watson launches Warner Chilcott's Zenchent
5 February 2007
First chewable birth control pill
11 December 2006
Generic drug antitrust settlement with US FTC
6 November 2006
New Warner Chilcott posts 1st-qtr loss
11 July 2005
Battle for Warner Chilcott may continue
8 November 2004
UPDATE: Ireland's Warner Chillcott mulls L1.7 billion offer from private equity group
27 September 2004
Warner Chilcott beats expectations
16 August 2004
Galen sees 2nd-qtr 2004 EPS rocket 84%
24 May 2004
Barr and Galen announce Loestrin and Ovcon 35 deals
5 April 2004
Galen reports 105% leap in 1st-qtr sales
16 February 2004
Galen gains US exclusivity period for Ovcon
26 January 2004
FDA approves new Ovcon 35
24 November 2003
Barr Labs and Galen in oral contraceptives licensing deal
22 September 2003
Galen seeking to buy Pfizer drugs for $359M
10 March 2003
Galen EPS leaps 35%, beating forecasts
17 February 2003
Galen 2nd-qtr profits and revenues soar
2 May 2001
Warner Chilcott acquires women's products from B-MS
28 January 2000
Showing 1-23 of 23 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
